Association of glucose transporter 4 genetic Polymorphisms with obstructive sleep apnea syndrome in Han Chinese general population: a cross-section study

Lipids in Health and Disease

Guijuan Chang¹  Ling Zhou¹  Jingjing Zhang¹  Juhong Zhang¹  Mulalibieke Heizhati¹  Nan fang Li¹  Ting Yin¹ 

[1] Institute of Hypertension of the People′s Hospital of Xinjiang Uyger Autonomous Region, Center of Diagnosis, Treatment and Research of Hypertension, Xinjiang, 91, Tianchi Road, Urumqi, Xinjiang, China

关键词: Glucose transporter 4;    Obstructive sleep apnea syndrome;    Genetics;   

Others  :  813963
DOI  :  10.1186/1476-511X-13-12

 received in 2013-10-10, accepted in 2014-01-07,  发布年份 2014

【 摘 要 】

Background

Obstructive sleep apnea syndrome (OSAS) is strongly associated with the increasing prevalence of cerebrovascular events and metabolic syndrome. A growing number of studies have shown OSAS is an independent factor for insulin resistance, glucose intolerance and type2 diabetes. However, relationship of OSAS with dysglycemia is complex and still remains poorly understood. Glucose transporter 4 (GLUT4) gene is Human and rodents’ main glucose transporter sensitive to insulin, and therefore confirmation of candidate gene polymorphisms and association with OSAS is needed. Aim of our study was to assess whether GLUT4 gene polymorphisms are associated with OSAS.

Methods

Patients hospitalized at People’s Hospital of Xinjiang were selected from January to December 2010. A total of 568 Han subjects who possibly exist OSAS base on a history and physical examination were completed the polysomnography, 412of whom (72.5%) were diagnosed with OSAS, and 156 individuals were confirmed without OSAS (27.5%). 96 severe OSAS patients chosen from OSAS were used for DNA sequencing in functional domain. Blood samples were collected from all subjects and genotyping was performed on DNA extracted from blood cells.

Results

We performed GLUT4 genome sequencing, found 4 mutated sites. And finally selected three mutated sites such as rs5415, rs4517 and rs5435, according to principle of linkage disequilibrium (r² > 0.8) and minimum gene allele frequency > 5%. All SNPs satisfied HEW (P > 0.05). Our study demonstrated a significant association of GLUT4 SNPrs5417 allele with OSAS, compared with controls (P < 0.05). Haplotype H1 (TCC) and H3 (CCC) defined as SNPrs5415, rs4517 and rs5435 are marginally associated with OSAS (P < 0.05). Frequencies of C haplotype of rs5417 in OSAS were higher than in controls. After adjustment for confounding factors, (AC + AA) genotype significantly reduces prevalence of OSAS, compared with CC genotype. Level of awake blood oxygen and lowest blood oxygen of (AA + AC) genotype was significantly superior to those of CC genotype.

Conclusions

Our study demonstrates GLUT4 gene SNPrs5417 is associated with OSAS in hypertensive population. Carriers of AA + AC have less prevalence of obstructive sleep apnea syndrome than that of CC carriers.

【 授权许可】

   
2014 Yin et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Stradling JR, Crosby JH: Predictors and prevalence of obstructive sleep apnoea and snoring in 1001 middle aged men. Thorax 1991, 46:85-90.
• [2]Young T, Palta M, Dempsey J, Skatrud J: The occurrence of sleep-disordered breathing among middleaged adults. N Engl J Med 1993, 328:230-235.
• [3]Amit Benjamin J, Lewis KE: Sleep-disordered breathing and cardiovascular disease. Postgrad Med J 2008, 84:15-22.
• [4]Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342(19):1378-1384.
• [5]Nieto FJ, Young TB, Lind BK, et al.: Association of sleepdisordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000, 283(14):1829-1836.
• [6]Vgontzas AN, Papanicolaou DA, Bixler EO, et al.: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85(3):1151-1158.
• [7]Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002, 165(5):670-676.
• [8]Drager LF, Jun JC, Polotsky VY: Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 2010, 24(5):843-851.
• [9]Kostoglou-Athanassiou I, Athanassiou P: Metabolic syndrome and sleep apnea. Hippokratia 2008, 12(2):81-86.
• [10]Vgontzas AN, Bixler EO, Chrousos GP: Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 2005, 9(3):211-224.
• [11]Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Ward SL, Tangredi MM: Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events: deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012, 8(5):597-619.
• [12]Bi YW, Yan ZT, Li NF, Cheng WP, Han RM, Zhang LL, Wang YC, Wang XL, Zu FY: A study of relationship between obstructive sleep apnea-hypopnea syndrome in hypertension and insulin. Zhonghua Nei Ke Za Zhi 2011, 50(9):734-738.
• [13]Steiropoulos P, Papanas N, Nena E, Tsara V, Fitili C, Tzouvelekis A, Christaki P, Maltezos E, Bouros D: Markers of glycemic control and insulin resistance in non-diabetic patients with obstructive sleep apnea hypopnea syndrome: does adherence to CPAP treatment improve glycemic control. Sleep Med 2009, 10(8):887-891.
• [14]Bonsignore MR, Eckel J: Metabolic aspects of obstructive sleep apnoea syndrome. Eur Respir Rev 2009, 18:113-124.
• [15]Miguel Angel L-F, Bain PA, Bizu G, Susan R, Williams MA: Sleep-disordered breathing and gestational diabetes mellitus: a meta-analysis of 9,795 participants enrolled in epidemiological observational studies. Diabetes Care 2013, 36:3353-3360.
• [16]Huang S, Czech MP: The GLUT4 glucose transporter. Cell Metab 2007, 5(4):237-252.
• [17]Si-cong CHEN, Ruo-an JIANG, Xiao-xiang ZHENG: The vesicle traffic and related clinical diseases of glucose transporter 4. Intl J Intern Med 2009, 10(36):606-609.
• [18]Barbara BK: Glucose transport: pivotal step in insulin action. Diabetes 1996, 45:1644-1654.
• [19]Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO: Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol 1991, 70:1593-1600.
• [20]Youn JH, Gulve EA, Henriksen EJ, Holloszy JO: Interactions between effects of W-7, insulin, and hypoxia on glucose transport in skeletal muscle. Am J Physiol 1994, 267:888-894.
• [21]Pamidi S, Tasali K: Obstructive sleep apnea and type 2 diabetes: is there any connection? Former neuroscience 2012, 3:126-134.
• [22]Ferini Strambi L, Fantini ML, Castronovo C: Epidemiology of obstructive s1eep apnea syndrome. Minerva Med 2004, 95(3):187-202.
• [23]Nan-fang LI, Rui-mei HAN, Zhi-tao YAN, Ying-chun WANG, Yun-wei BI, Wei-ping CHENG, Li-li ZHANG, Fei-ya ZU, Qiu-yan CHENG: Analysis of cardiovascular risk factors in hypertensive patients with obstructive sleep apnea hypopnea syndrome. Chinese J Hypertens 2011, 4(19):361-364.
• [24]Bi Y-w, Yan Z-t, Cheng W-p: Metabolic characters in obstructive sleep apnoea patients in hypertension. Heart 2012, 98:E256.
• [25]Lavie L: Oxidative stress—a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 2009, 51(4):303-312.
• [26]Monneret D, Pepin JL, Godin-Ribuot D, et al.: Association of urinary 15-F2t-isoprostane level with oxygen desaturation and carotid intima-media thickness in nonobese sleep apnea patients. Free Radic Biol Med 2010, 48(4):619-625.
• [27]Tan KC, Chow WS, Lam JC, et al.: Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea. Sleep 2006, 29(3):329-333.
• [28]Calvin AD, Albuquerque FN, Lopez-Jimenez F, Somers VK: Obstructive sleep apnea, inflammation, and the metabolic syndrome. Metab Syndr Relat Disord 2009, 7(4):271-278.
• [29]Bonizzi G, Karin M: The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004, 25:280-288.
• [30]Juleen RZ, Tsao T-S: Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complemen. J Biol Chem 1998, 273:20910-20915.
• [31]Hommelberg PP, J J, Langen RC, Schols AM, Mensink RP: Fatty acid-induced NF-_B activation and insulin resistance in skeletal muscle are chain length dependent. Am J Physiol Endocrinol Metab 2009, 296:E114-E120.
• [32]Silke Ryan MD, Cormac T, Taylor PD, Walter T, McNicholas MD: Predictors of elevated tumour necrosis factor a level in obstructive sleep apnoea syndrome. Eur Respir Rev 2006, 15(101):221-223.
• [33]Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF: Chronic intermittent hypoxia activates nuclear factor-kB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 2006, 343:591-596.
• [34]Kletsas D, Pratsinis H, Mariatos G, Zacharatos P, Gorgoulis VG: The proinflammatory phenotype of senescent cells: the p53-mediated ICAM-1 expression. Ann N Y Acad Sci 2004, 1019:330-332.
• [35]Alan Saltiel RA: The molecular pathogenesis and treatment of new ideas of type 2 diabetes. Plant Cell 2001, 104:517-529.
• [36]Tangvarasittichai S, Poonsub P, Tangvarasittichai O: Association of serum lipoprotein ratios with insulin resistance in type 2 diabetes mellitus. Indian J Med Res 2010, 131:641-648.
• [37]Saini V: Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J Diabetes 2010, 1(3):68-75.
• [38]Punjabi NM, Beamer BA: Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care 2009, 179:235-240.
• [39]Dong CHEN, Ming-wei CHEN, Ning-ning YANG, et al.: p38MAPK signaling pathways affect the expression of GLUT4 in skeletal muscle insulin resistance model. Anhui Med Pharm J 2012, 16(9):1237-1240.
• [40]Niu W, Huang C, Nawaz Z, et al.: Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. BiolChem 2003, 278(20):17953-17962.
• [41]Xu LIU, FENG S-j, ZHANG C-y: Experimental studies on hypoxic preconditioning-induced neuroprotection against focal ischemic injury of mice and its p38 MAPK mechanism. Journal of Capital Medical University 2009, 30(5):643-647.
• [42]Lu WY, Zhao MF, Chai X, Meng JX, Zhao N, Rajbhandary S, Xu XN, Ma L, Li YM: Reactive oxygen species mediate the injury and deficient hematopoietic supportive capacity of umbilical cord derived mesenchymal stem cells induced by iron overload. Zhonghua Yi Xue Za Zhi 2013, 93(12):930-934.
• [43]Nishimura M, Sugino T, Nozaki K, et al.: Activation o f p38 kinase in the gerbilhippocam pus showing ischemic tolerance. J Cereb Blood Flow Metab 2003, 23:1052-1059.
• [44]Lavie L, Lavie P: Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009, 33:1467-1484.
• [45]Keren A, Tamir Y, Bengal E: The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 2006, 252:224-230.
• [46]Hongxia R, Domenico A, Cunming D: Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways. Proc Natl Acad Sci USA 2010, 107(13):5857-5862.
• [47]He-feng WANG, Chun-gang ZHAI, Wen-hui PANG, Chen WANG, Min YANG, Kai ZHAO, Da-qing LI, Yun ZHANG, Ji-fu LI, Wen-qiang CHEN: Roles of PI3K/Akt /mTOR signaling pathway in macrophage autophagy and atherosclerotic plaque instability. Chinese J Pathophysiol 2013, 29(3):390-397.
• [48]Priou P, Le Vaillant M, Meslier N, Chollet S, Masson P, Humeau MP, Pigeanne T, Bizieux-Thaminy A, Goupil F, Gagnadoux F: Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes. Diabetes Care 2012, 35(9):1902.
• [49]Weinstock Weinstock TG, Wang X, Rueschman M, Ismail-Beigi F, Aylor J, Babineau DC, Mehra R, Redline S: A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 2012, 35:617-625.
• [50]Zierath JR, Tsu-Shuen T, Stenbit AE, Ryder JW, Dana G, Charron MJ: Restoration of hypoxia-stimulated glucose uptake in GLUT4-deficient muscles by muscle-specific GLUT4 transgenic complementation. J Biol Chem 1998, 273:20910-20915.
• [51]Yardim-Akaydin S, Caliskan-Can E, Firat H, Ardiç S, Simsek B: Influence of gender on C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in obstructive sleep apnea. Anticancer Agents Med Chem 2013, 9:267-272.
• [52]Nair AK, Sugunan D, Kumar H, Anilkumar G: Case–control analysis of SNPs in GLUT4, RBP4 and STRA6: association of SNPs in STRA6 with type 2 diabetes in a South Indian population. PLoS One 2010, 5(7):e11444.
• [53]Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subject. Washington, DC: National Institutes of Health; 1968. [204]